3 Penny Stocks to Watch Now, 4/21/26

Penny stocks are inexpensive shares that usually trade below $5 apiece and are most often issued by companies with market capitalization of roughly $300 million or less. Enveric Biosciences (ENVB), Psyence Biomedical (PBM), and Theriva Biologics (TOVX) are the three penny stocks to watch on April 21, according to TipRanks' Penny Stock Screener tool.Claim 30% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks These names were picked because they recorded the largest dollar trading volumes at the close on Monday, April 20. This means that they had the highest total value of shares that changed hands, computed by multiplying the number of shares traded by the stock's price. Enveric Biosciences (ENVB): This is a Naples, Florida-based pharmaceutical company that develops various medicines that use various active compounds found in cannabis to treat cancer. On Monday, April 15, Enveric shares closed roughly 101% higher, hitting a dollar trading volume of $579.27 million. ENVB was one of several psychedelic biotech stocks that soared on that day after President Donald Trump on Saturday, April 18, signed the executive order "Accelerating Medical Treatments for Serious Mental Illness." The order provides for faster regulatory review of psychedelic drugs with Breakthrough Therapy status and commits $50 million for research into compounds such as ibogaine and psilocybin, among others. Psyence Biomedical (PBM): Psyence is a Toronto, Canada-based biotech company that develops psilocybin-based psychedelic medicines. On April 15, the company's shares ended the day about 49% higher and reached a dollar volume of $477.70 million. Like ENVB stock, Psyence shares surged following the psychedelic update from the Trump administration. Theriva Biologics (TOVX): Theriva is a clinical-stage biotech company that develops therapies for difficult-to-treat solid tumors. On April 15, TOVX hit a dollar volume of $265.92 million after its shares rocketed about 60% higher. The boost came after Theriva announced positive data from its Phase 2b clinical trial for cancer drug VCN-01 plus chemotherapy in metastatic pancreatic cancer patients. More about TipRanks' Penny Stock Screener Analysts looking to stay up-to-date with penny stocks can rely on TipRanks' Penny Stock Screener tool, which makes it possible for investors to check out the thousands of penny stocks traded daily in the U.S. using filters such as sector, price target upside, Smart Score, analyst consensus, dollar volume, and price change.